Search results
Results from the WOW.Com Content Network
Hematology (spelled haematology in British English) is the branch of medicine concerned with the study of the cause, prognosis, treatment, and prevention of diseases related to blood. [ 1 ] [ 2 ] It involves treating diseases that affect the production of blood and its components, such as blood cells , hemoglobin , blood proteins , bone marrow ...
Harmonizing hematology education: EHA is an independent provider of hematology education, with a comprehensive and integral curriculum that forms the basis of EHA Medical Education Program. Through this program, professionals acquire knowledge by various means, such as an online learning platform, educational meetings and a European Hematology ...
Immunohematology is a branch of hematology and transfusion medicine which studies antigen-antibody reactions and analogous phenomena as they relate to the pathogenesis and clinical manifestations of blood disorders.
This is an incomplete list, which may never be able to satisfy certain standards for completion.. There are many conditions of or affecting the human hematologic system—the biological system that includes plasma, platelets, leukocytes, and erythrocytes, the major components of blood and the bone marrow.
Hematological malignancies. Lymphomas. Hodgkin's disease; Non-Hodgkin's lymphoma {includes the next five entries} . Burkitt's lymphoma; Anaplastic large cell lymphoma; Splenic marginal zone lymphoma
The society publishes the medical journal Blood, the most cited peer-reviewed publication in the field, [2] and Blood Advances, an online, peer-reviewed open-access journal. [3] [4] The first official ASH meeting was held in Atlantic City, New Jersey, in April 1958.
At St Mary's, Bain developed a training program on haematology, covering topics such as the analysis of blood and bone marrow samples and genetic disorders that affect haemoglobin. She helped to develop bloodmed.com, an online educational course that is taken by almost all UK trainees.
Acute promyelocytic leukemia is characterized by a chromosomal translocation involving the retinoic acid receptor alpha (RARA) gene on chromosome 17. [3] In 95% of cases of APL, the RARA gene on chromosome 17 is involved in a reciprocal translocation with the promyelocytic leukemia gene (PML) on chromosome 15, a translocation denoted as t(15;17)(q22;q21). [3]